Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases
Technology
E-267-2016
Patent ID
E-267-2016-0-US-05
Country
US
Application Type
National Stage
Patent Status
Issued
Patent Number
10363286
Publication Number
US20170304401A1
Application Number
15/639,434
IC
NCI
Date Filed
Date Issued